Skip to Content Facebook Feature Image

BOYA mini Launched: the World's Tiniest Wireless Microphone

Business

BOYA mini Launched: the World's Tiniest Wireless Microphone
Business

Business

BOYA mini Launched: the World's Tiniest Wireless Microphone

2024-11-25 22:09 Last Updated At:22:25

NEW YORK, Nov. 25, 2024 /PRNewswire/ -- BOYA, renowned for combining audio technology with stylish design, unveils the BOYA mini Wireless Microphone in Jakarta, Indonesia, on November 25, 2024. This sleek, ultra-light mic crafted for the next generation of content creators. Weighing just 5 grams, this compact microphone is the tiniest wireless microphone in the world. Once again, BOYA redefines consumer wireless microphone technology, setting a new standard for style and performance in the market.

More Mighty and More Mini

BOYA's best-kept secret is the mini Wireless Microphone. Its streamlined design integrates seamlessly with clothing, offering a weightless feel for recording anywhere. BOYA engineers brought the vision of a compact, modern device to life. "Every detail was meticulously crafted to maximize performance while minimizing size." says Lucas Xu, Product Manager at BOYA.

Magic Sound, Clipping Free

The BOYA mini Wireless Microphone delivers exceptional audio fidelity with 48 kHz/16-bit audio and a frequency response of 20 Hz to 20 kHz, ensuring precise detail. With an 80 dB signal-to-noise ratio, it guarantees pure sound quality. The transmitter features BOYA's advanced limiter technology, preventing audio signal peaks from distortion and clipping at up to 120 dB SPL, delivering true and rich sound.

Clear Sound with a Creative Touch

Featuring a built-in DSP noise cancellation chip and three ENC modes, this wireless microphone excels in delivering clear audio across various environments. Its voice-changing modes add an engaging element, making it ideal for vibrant live shoots and dynamic interviews.

Ready When You Are

Each transmitter offers up to 6 hours of use on a single charge, while the charging case extends this to 30 hours, ensuring reliable performance during long recording sessions. Designed with versatility in mind, the BOYA mini Wireless Microphone adapts seamlessly to diverse scenarios, from gaming to vlogging, while allowing users to express their unique style effortlessly.

The Availability of BOYA mini

The BOYA mini wireless microphone is now available to creators worldwide through our website, https://www.boyamic.com/, with a recommended price range of $45-$60. It comes in both white and black color options.

About BOYA

Since 2012, BOYA has been committed to inspiring creativity through innovative audio technology. We create products for today's fun-loving, youthful creators, delivering seamless recording experiences that bring stories to life with clarity and style.

For business and marketing cooperation, contact BOYA via: https://www.boyamic.com/about/contact 

Media Contact: 
Jingyi Chen
chenjinyi@sz-cf.cn 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

BOYA mini Launched: the World's Tiniest Wireless Microphone

BOYA mini Launched: the World's Tiniest Wireless Microphone

Twenty studies validate AI performance across diverse populations and clinical settings, including award-winning research in emergency radiology

SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced its participation in the Radiological Society of North America (RSNA) 2024 Annual Meeting, presenting a record-breaking 20 abstracts. As RSNA 2024 highlights the transformative role of AI in radiology, Lunit's groundbreaking research and solutions emphasize how AI can address critical challenges in healthcare, from improving diagnostic accuracy to enhancing clinician efficiency.

Among Lunit's studies, two groundbreaking research presentations stand out:

1. Enhancing Breast Cancer Detection Across Diverse Populations

Presented by Dr. Hari Trivedi from Emory University, the study focuses on Lunit INSIGHT DBT, an AI-powered solution for breast cancer detection using digital breast tomosynthesis (DBT) images. Conducted on a large, racially heterogeneous screening population from Emory University (137,460 cases from 2013-2020), the research demonstrated Lunit AI's consistent performance across various subgroups, including race, ethnicity, age, and breast density.

Key findings include:

2. Empowering Clinicians Through AI-Assisted Chest X-Ray Interpretation

Presented by Dr. Ruchir Shah from Oxford University Hospitals and awarded the Trainee Research Prize - Resident, this study evaluated the impact of Lunit INSIGHT CXR, an AI-powered solution for chest X-ray interpretation, on clinician performance in emergency and inpatient care settings.

The study involved 30 clinicians from various specialties and experience levels, who interpreted 500 chest X-rays with and without AI assistance on the RAIQC platform.

Notable results include:

"RSNA 2024's focus on AI in radiology aligns seamlessly with Lunit's mission to conquer cancer through AI," said Brandon Suh, CEO of Lunit. "The studies we're presenting this year exemplify how our AI solutions address real-world challenges—ensuring diagnostic equity in breast cancer detection and empowering clinicians with improved accuracy for critical chest X-ray findings. These innovations are about reshaping the standard of care for diverse patient populations globally. We are honored to contribute to this year's discussion on AI's role in radiology and look forward to sharing how Lunit is driving meaningful impact in the field."

The RSNA 2024 Annual Meeting will take place in Chicago, Illinois, from December 1-6, 2024. For more information, visit Lunit's booth #4929 in the AI Showcase.

Presentations at RSNA 2024 featuring the Lunit INSIGHT suite include:

About Lunit

Founded in 2013, Lunit (KRX:328130.KQ) is a medical AI company on a mission to conquer cancer. We harness AI-powered medical image analytics and AI biomarkers to ensure accurate diagnosis and optimal treatment for each cancer patient. The FDA-cleared Lunit INSIGHT suite for cancer screening serves over 4,500 hospitals and medical institutions across 55+ countries.

Lunit clinical studies have been published in top journals, including the Journal of Clinical Oncology and the Lancet Digital Health, and presented at global conferences such as ASCO and RSNA. In 2024, Lunit acquired Volpara Health Technologies, setting the stage for unparalleled synergy and accuracy, particularly in breast health and screening technologies. Headquartered in Seoul, South Korea, with a network of offices worldwide, Lunit leads the global fight against cancer. Discover more at lunit.io.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Lunit to Showcase Research Contributions at RSNA 2024 with Record-Breaking 20 Abstracts

Lunit to Showcase Research Contributions at RSNA 2024 with Record-Breaking 20 Abstracts

Recommended Articles